一般演題口演 CKD English

[O-252] Finerenone increases the likelihood of improved KDIGO risk category in patients with type 2 diabetes and CKD：an analysis from FIDELITY

^○Terumasa Hayashi¹, Silvio E. Inzucchi², Gerasimos Filippatos³, Stefan D. Anker⁴, Christoph Wanner⁵, Tariq Shafi⁶, Navdeep Tangri⁷, Bertram Pitt⁸, Robert Weingold², Meike Brinker⁹, Charlie Scott⁹, Luke Roberts⁹, Peter Rossing¹⁰ (1.Osaka General Medical Center, Japan, 2.Yale School of Medicine, USA, 3.National and Kapodistrian University of Athens, Greece, 4.Charité Universitätsmedizin, Germany, 5.Universitätsklinik Würzburg, Germany, 6.Houston Methodist Academic Institute, USA, 7.Max Rady College of Medicine, Canada, 8.University of Michigan School of Medicine, USA, 9.Bayer, 10.Steno Diabetes Center Copenhagen, Denmark)